002349 logo

Jinghua Pharmaceutical Group Co., Ltd. Stock Price

SZSE:002349 Community·CN¥6.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

002349 Share Price Performance

CN¥0
-8.47 (-100.00%)
CN¥0
-8.47 (-100.00%)
Price CN¥0

002349 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet, good value and pays a dividend.

1 Risk
2 Rewards

Jinghua Pharmaceutical Group Co., Ltd. Key Details

CN¥1.4b

Revenue

CN¥712.9m

Cost of Revenue

CN¥736.3m

Gross Profit

CN¥511.5m

Other Expenses

CN¥224.8m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.27
50.81%
15.51%
0%
View Full Analysis

About 002349

Founded
1957
Employees
1490
CEO
Jian Cheng
WebsiteView website
www.jinghuapharm.com

Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China. Its primary products include Phenobarbital, Primidone, Fluorouracil, Phenylbutazone, Flucytosine, Piroxicam, and Propylthiouracil APIs. The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. The company was founded in 1957 and is based in Nantong, China.

Recent 002349 News & Updates

Recent updates

No updates